SERPINF1 and cancer: Correspondingly, THY-1 cell surface antigen (CD90), tissue inhibitor of metalloproteinase (TIMP)-4 and SERPIN F1, previously reported to negatively regulate invasion of cancer cells, were found to be downregulated (Figure 5B, 5C) [21–23].